11,300 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Acquired by TCW Group Inc.

TCW Group Inc. purchased a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,300 shares of the pharmacy operator’s stock, valued at approximately $301,000.

A number of other hedge funds have also modified their holdings of WBA. Cambridge Investment Research Advisors Inc. raised its stake in Walgreens Boots Alliance by 15.3% during the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 301,910 shares of the pharmacy operator’s stock valued at $7,883,000 after purchasing an additional 40,095 shares during the period. Ontario Teachers Pension Plan Board boosted its position in shares of Walgreens Boots Alliance by 657.8% during the fourth quarter. Ontario Teachers Pension Plan Board now owns 118,383 shares of the pharmacy operator’s stock worth $3,091,000 after acquiring an additional 102,762 shares during the last quarter. Financial Advisors Network Inc. purchased a new position in Walgreens Boots Alliance during the fourth quarter valued at $229,000. EverSource Wealth Advisors LLC increased its holdings in Walgreens Boots Alliance by 79.6% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,010 shares of the pharmacy operator’s stock valued at $52,000 after acquiring an additional 891 shares during the last quarter. Finally, Assetmark Inc. lifted its stake in Walgreens Boots Alliance by 2,015.4% in the 4th quarter. Assetmark Inc. now owns 13,623 shares of the pharmacy operator’s stock worth $356,000 after purchasing an additional 12,979 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms recently commented on WBA. Truist Financial reiterated a “hold” rating and issued a $25.00 target price on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. Raymond James reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. Leerink Partnrs reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. SVB Leerink dropped their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a research note on Monday, March 18th. Finally, HSBC reissued a “reduce” rating and set a $20.00 target price (down from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $24.36.

View Our Latest Research Report on Walgreens Boots Alliance

Insider Buying and Selling

In other Walgreens Boots Alliance news, CFO Manmohan Mahajan acquired 6,000 shares of the firm’s stock in a transaction on Tuesday, April 2nd. The stock was acquired at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the purchase, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, CFO Manmohan Mahajan bought 6,000 shares of the stock in a transaction dated Tuesday, April 2nd. The shares were purchased at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, April 11th. The shares were bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is owned by corporate insiders.

Walgreens Boots Alliance Trading Up 0.5 %

Walgreens Boots Alliance stock opened at $16.03 on Monday. Walgreens Boots Alliance, Inc. has a one year low of $15.89 and a one year high of $32.89. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. The stock has a market cap of $13.83 billion, a PE ratio of -2.29, a price-to-earnings-growth ratio of 1.00 and a beta of 0.80. The stock has a 50-day moving average of $18.46 and a two-hundred day moving average of $21.15.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping the consensus estimate of $0.82 by $0.38. The business had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.16 earnings per share. On average, research analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.22 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be given a $0.25 dividend. The ex-dividend date is Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a yield of 6.24%. Walgreens Boots Alliance’s dividend payout ratio is currently -14.29%.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.